Iran, Islamic Republic of vs Other small states: Immunization, Hib3
Immunization, Hib3 over time
- Iran, Islamic Republic of
- Other small states
How they compare
Iran, Islamic Republic of currently reports 98.0% against 85.6% in Other small states, a difference of 12.4%.
That makes Iran, Islamic Republic of's figure about 1.1 times Other small states's.
Across all 10 years both countries report, Iran, Islamic Republic of has been ahead every year.
Iran, Islamic Republic of ranks 20th and Other small states ranks 18th of 191 countries.
Iran, Islamic Republic of has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Iran, Islamic Republic of | Other small states | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 98.8% | 88.6% | 10.2% | Iran, Islamic Republic of |
| 2020s | 98.6% | 85.3% | 13.3% | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher immunization, hib3, Iran, Islamic Republic of or Other small states?
- Iran, Islamic Republic of, at 98.0% against 85.6% in Other small states as of 2024.
- What is the difference in immunization, hib3 between Iran, Islamic Republic of and Other small states?
- 12.4%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Iran, Islamic Republic of and Other small states?
- 10 years are reported by both, from 2015 to 2024.
- How do Iran, Islamic Republic of and Other small states rank globally for immunization, hib3?
- Iran, Islamic Republic of ranks 20th and Other small states ranks 18th of 191 countries.
- Where does this data come from?
- WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/), published as Immunization, Hib3 (% of children ages 12-23 months). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Child immunization, Hib3, measures the percentage of children ages 12-23 months who received Hib3 vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against Hib3 after receiving three doses of Haemophilus influenzae type b vaccine.